Title:
インターロイキン－３４を標的とする化合物及び方法
Document Type and Number:
Japanese Patent JP2023524515
Kind Code:
A
Abstract:
本発明は、ＩＬ－３４抗体、それを含む組成物、並びに神経変性疾患、例えばアルツハイマー病又はタウオパチー疾患などの免疫介在性疾患を治療するための抗体及び／又はその組成物の使用方法に関する。【選択図】
Inventors:
Shedido, Marcio
Obung, Victor H.
Skola, Andrew Dixon
Yeah, Min
Obung, Victor H.
Skola, Andrew Dixon
Yeah, Min
Application Number:
JP2022566385A
Publication Date:
June 12, 2023
Filing Date:
April 23, 2021
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
C12N15/13; A61K39/395; A61P1/04; A61P3/06; A61P13/12; A61P17/04; A61P19/02; A61P25/28; A61P31/04; C07K16/24; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; C12P21/02; C12P21/08
Attorney, Agent or Firm:
Norito Yamao
Nagatoshi Shinagawa
Wu Yingyan
Nagatoshi Shinagawa
Wu Yingyan
Previous Patent: Tilt tongue cannula depth limiter
Next Patent: Showerhead grouping feature in substrate processing system
Next Patent: Showerhead grouping feature in substrate processing system